Skip to main content

A cinema in Beijing is shown in this file photo.

Ng Han Guan/AP

Chinese conglomerate Dalian Wanda Group is interested in buying more U.S. theatre chains following its purchase of cineplex owner AMC Entertainment, the company's chairman said on Tuesday.

Further deals would be part of the Chinese company's plan to invest $10-billion in U.S. acquisitions, Wanda Group chairman Wang Jianlin told reporters. The purchases would be made by AMC on Wanda's behalf, he said.

"We see other possible (merger and acquisition) opportunities, but we can't lose sight of the need for them to be profitable," he said.

Story continues below advertisement

Wanda also is talking with the five largest Hollywood studios about the possibility of investing in films or creating movie funds with the studios, Mr. Jianlin said.

Wanda announced the completion of its $2.6-billion purchase of theatre owner AMC on Tuesday, creating the world's largest theatre chain.

Dalian Wanda Group Co.'s purchase reflects the global ambitions of cash-rich Chinese companies that are using acquisitions to speed their expansion.

The Beijing-based company said it will invest an additional $500-million in AMC and keep its headquarters in Kansas City, Mo.

AMC, which operates 338 cinemas, is owned by a group of private-equity firms.

Wanda, founded in 1988 and privately owned, operates hotels, department stores, tourism and other businesses. It has 94 theatres in China.

With files from AP

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter